Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

28,435 signal articles · 179 in last 24h · 139,003 total before filter · latest 56m ago
179last 24h
935last 7d
136● bullish (7d)
117● bearish (7d)
209publishers
AllMacro249Earnings262M&A87Regulatory16Product9Analyst15
Sentiment:bullishneutralbearishshow all (incl. clickbait)
XRP new addresses sink to 18-month low
TheStreet125d agoneutral
XRP new addresses sink to 18-month low

The number of new addresses appearing on the XRP network has dropped from 18,000 a day in December to 2,700 a day on May 7, as per Glassnode data. The figure hitting an 18-month low represents a decline of 85% during the period. Monthly active XRP supply has also sunk from 7.45 ...

New Blackstone REIT to offer pure-play data center exposure
TheStreet125d agoneutral
New Blackstone REIT to offer pure-play data center exposure

Those who live and die by the staying power of the AI boom might soon have a pure-play way to gain exposure to the data center category. Last week, Blackstone filed to debut a brand new data center REIT, the Blackstone Digital Infrastructure Trust ($BXDC). The fresh listing will open up the private ...

Block (XYZ) Q1 Earnings Surpass Estimates
Zacks125d agoneutral
Block (XYZ) Q1 Earnings Surpass Estimates

Block (XYZ) delivered earnings and revenue surprises of +25.68% and -0.81%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

MercadoLibre (MELI) Lags Q1 Earnings Estimates
Zacks125d agoneutral
MercadoLibre (MELI) Lags Q1 Earnings Estimates

MercadoLibre (MELI) delivered earnings and revenue surprises of -6.26% and +4.85%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Palantir CEO issues blunt warning to 'AI slop' competitors
TheStreet125d agoneutral
Palantir CEO issues blunt warning to 'AI slop' competitors

There's a phrase Palantir CEO Alex Karp kept coming back to on the company's first-quarter 2026 earnings call: "AI slop." He used it to describe what he believes most AI competitors are selling: polished demos, convincing pitches, and outputs that fall apart the moment they meet a real enterprise. ...

Morgan Stanley raises price targets across semiconductor sector
TheStreet125d agoneutral
Morgan Stanley raises price targets across semiconductor sector

Morgan Stanley is leaning bullish on semiconductor stocks at a time when the sector is already on fire. The iShares Semiconductor ETF(SOXX) is up 51% this year, and instead of calling a top, the firm just raised price targets for names like IonQ (IONQ), Microchip (MCHP), and ...

iShares Gold Trust vs SPDR Gold Trust: The 0.15% Fee Gap That Matters More Than You Think
24/7 Wall St.125d agoneutral
iShares Gold Trust vs SPDR Gold Trust: The 0.15% Fee Gap That Matters More Than You Think

Gold has done what gold does best in tough macro stretches. With CPI running at 3.7% and the 10-year Treasury at 4.36%, investors are once again debating which physically backed gold ETF to own. SPDR Gold Trust (NYSEARCA:GLD) and iShares Gold Trust (NYSEARCA:IAU) hold essentially the same asset, yet they appeal to different buyers. The ... iShares Gold Trust vs SPDR Gold Trust: The 0.15% Fee Gap That Matters More Than You Think

Codexis Q1 Earnings Call Highlights
MarketBeat125d agoneutral
Codexis Q1 Earnings Call Highlights

Codexis (NASDAQ:CDXS) reported first-quarter 2026 revenue of $15.2 million, up from $7.5 million a year earlier, as the company highlighted continued progress commercializing its ECO Synthesis enzymatic manufacturing platform for RNA medicines and reiterated full-year revenue guidance of $72 million

Rocket Lab Stock Surges. The Space Race Is On.
Barrons.com125d agobullish
Rocket Lab Stock Surges. The Space Race Is On.

A year ago, Rocket Lab reported a gross profit of $35.2 million from sales of $122.6 million. Looking ahead, Rocket Lab expects second-quarter sales of $225 million to $240 million. Rocket Lab stock was up 5.9% in after-hours trading at $83.21.

Cloudflare Stock Tumbles. An Earnings Beat Wasn’t Enough.
Barrons.com125d agobearish
Cloudflare Stock Tumbles. An Earnings Beat Wasn’t Enough.

Cloudflare stock was falling sharply in late Thursday despite better-than-expected first-quarter results from the cybersecurity company. Cloudflare reported adjusted earnings of 25 cents a share on revenue of $639.8 million. Analysts surveyed by FactSet were expecting earnings of 23 cents a share on revenue of $621 million.

Texas Roadhouse (TXRH) Meets Q1 Earnings Estimates
Zacks125d agoneutral
Texas Roadhouse (TXRH) Meets Q1 Earnings Estimates

Texas Roadhouse (TXRH) delivered earnings and revenue surprises of +0.13% and -0.06%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Airbnb, Inc. (ABNB) Q1 Earnings Miss Estimates
Zacks125d agobearish
Airbnb, Inc. (ABNB) Q1 Earnings Miss Estimates

Airbnb (ABNB) delivered earnings and revenue surprises of -15.23% and +2.16%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Airbnb Beats Expectations for Revenue, Gross Bookings Value. The Stock Is Falling.
Barrons.com125d agobullish
Airbnb Beats Expectations for Revenue, Gross Bookings Value. The Stock Is Falling.

Vacation rental site Airbnb reported first-quarter revenue and gross bookings that beat expectations and raised its full-year guidance, but also said travel plans are being impacted by the conflict in the Middle East. At the same time, online travel agency Expedia Group missed first-quarter revenue expectations but reported record first-quarter profit and higher-than-expected gross bookings. Airbnb said first-quarter revenue increased 18% from a year ago to $2.7 billion, “exceeding the high end of our guidance.”

Gilead Earnings Show HIV Drugs Continue to Shine. Why the Guidance Cut?
Barrons.com125d agobearish
Gilead Earnings Show HIV Drugs Continue to Shine. Why the Guidance Cut?

Gilead Sciences beat analysts’ earnings and revenue expectations in its latest quarter. Gilead logged adjusted earnings of $2.03 a share, ahead of the $1.91 consensus among analysts polled by FactSet. Gilead’s top-line growth rested heavily on Biktarvy, its blockbuster HIV treatment, which accounted for nearly half of total revenue as sales rose 8% to $3.4 billion.

Bloomberg125d agobearish
Lyft Earnings Miss Estimates After Global Expansion Push

(Bloomberg) -- Lyft Inc. reported profit in the first quarter that fell short of Wall Street’s estimates after it spent heavily on an international expansion and on adding higher-end offerings like chauffeur services.Most Read from BloombergBillionaire Duke of Westminster to Sell £700 Million of US Real Estate AssetsUS Has Opened a Passage Through Hormuz, Central Command SaysDOJ Plans Intervention in Trump Supreme Court Carroll AppealChina Asks Banks to Pause New Loans to US-Sanctioned RefinerSo

Trump meets with Brazil's Lula to talk trade, extends EU tariff deadline
Yahoo Finance Video125d agoneutralVIDEO
Trump meets with Brazil's Lula to talk trade, extends EU tariff deadline

President Trump met with Brazilian President Luiz Inácio Lula da Silva on Thursday, while the administration extended its trade deadline with the European Union (EU) to July 4. Yahoo Finance Washington Correspondent Ben Werschkul speaks more about what this meeting could mean for US-Brazil relations and the latest news about Trump's 25% tariffs against EU cars.